IDXX
IDEXX Laboratories Inc
519.30$
+1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 44.8% | 45.9% | 44.8% | 44.8% | 42.8% | 42.5% | 41.0% | 40.9% | 41.5% | 40.0% | 43.0% | 43.9% | |
| 10.7% | 13.9% | 11.9% | 11.8% | 9.2% | 8.8% | 5.1% | 4.9% | 6.1% | 5.4% | 5.9% | 5.7% | |
| 10.7% | 13.9% | 11.9% | 11.8% | 9.2% | 8.8% | 5.1% | 4.9% | 6.1% | 5.4% | 5.9% | 5.7% | |
| 16.9% | 16.2% | 17.2% | 17.8% | 17.5% | 14.4% | 18.8% | 19.9% | 21.1% | 20.7% | 20.6% | 21.5% | |
| 12.8% | 11.7% | 11.6% | 11.1% | 11.6% | 11.6% | 12.3% | 11.8% | 11.6% | 11.3% | 11.3% | 11.4% | |
| 11.7% | 11.2% | 12.2% | 11.9% | 12.3% | 12.3% | 12.7% | 12.4% | 12.2% | 12.4% | 12.2% | 11.9% | |
| 2.8% | 2.6% | 3.4% | 3.2% | 3.2% | 3.4% | 3.3% | 3.1% | 3.4% | 3.3% | 3.1% | 2.9% | |
| 58.0% | 54.5% | 53.2% | 53.7% | 51.7% | 51.6% | 54.9% | 56.2% | 53.9% | 52.1% | 54.0% | 53.2% | |
| 31.4% | 29.2% | 28.5% | 32.7% | 30.1% | 32.4% | 35.4% | 36.7% | 37.0% | 34.3% | 38.4% | 37.4% | |
| 13.6% | 10.6% | 10.3% | 12.9% | 11.0% | 5.1% | 15.9% | 20.4% | 18.7% | 14.9% | 20.9% | 20.2% | |
| 3.6% | 3.4% | 3.5% | 3.4% | 3.3% | 3.5% | 3.7% | 3.5% | 3.6% | 3.3% | 3.8% | 3.8% | |
| 20.0% | 19.1% | 18.5% | 15.4% | 15.7% | 13.7% | 14.0% | 13.5% | 11.1% | 11.2% | 8.9% | 8.7% | |
| 42.0% | 45.5% | 46.8% | 46.3% | 48.3% | 48.4% | 45.1% | 43.8% | 46.1% | 47.9% | 46.0% | 46.8% | |
| 137.7% | 136.3% | 139.6% | 143.0% | 152.7% | 161.9% | 173.5% | 176.2% | 181.4% | 190.8% | 197.0% | 203.6% | |
| 2.7% | 2.6% | 2.5% | 2.4% | 2.5% | 2.5% | 2.5% | 2.4% | 2.4% | 2.4% | 2.4% | 2.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.